Corpus ID: 5068146

Perspective: Melanoma diagnosis and monitoring: Sunrise for melanoma therapy but early detection remains in the shade

@inproceedings{Spanjaard2018PerspectiveMD,
  title={Perspective: Melanoma diagnosis and monitoring: Sunrise for melanoma therapy but early detection remains in the shade},
  author={Remco A. Spanjaard and David Weaver and Shyamsunder Erramilli and Pritiraj Mohanty},
  year={2018}
}
  • Remco A. Spanjaard, David Weaver, +1 author Pritiraj Mohanty
  • Published 2018
  • Medicine, Biology
  • Melanoma is one of the most dangerous forms of cancer. The five-year survival rate is 98% if it is detected early. However, this rate plummets to 63% for regional disease and 17% when tumors have metastasized, that is, spread to distant sites. Furthermore, the incidence of melanoma has been rising by about 3% per year, whereas the incidence of cancers that are more common is decreasing. A handful of targeted therapies have recently become available that have finally shown real promise for… CONTINUE READING

    Create an AI-powered research feed to stay up to date with new papers like this posted to ArXiv

    References

    Publications referenced by this paper.
    SHOWING 1-10 OF 23 REFERENCES

    Nanosensors for Breast Cancer Diagnosis Review in Biosensors and Molecular Technologies for Cancer Diagnostics, edited by K

    • P Mohanty, Y Chen, +4 authors E Erramilli
    • 2012